Makoto Nishikawa
- Infectious Diseases top 10%
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Liver physiology and pathology 4
- Epidemiology top 10%
- Respiratory viral infections research 8
- Influenza Virus Research Studies 7
- Neuroendocrine Tumor Research Advances 5
- Animal Science and Zoology top 10%
-
- Pancreatic and Hepatic Oncology Research 13
-
- Gallbladder and Bile Duct Disorders 5
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
In The Last Decade
Makoto Nishikawa
51 papers receiving 725 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 243
- Hepatology 101
- Epidemiology 400
- Animal Science and Zoology 79
- Cardiology and Cardiovascular Medicine 148
Countries citing papers authored by Makoto Nishikawa
This map shows the geographic impact of Makoto Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Nishikawa more than expected).
Fields of papers citing papers by Makoto Nishikawa
This network shows the impact of papers produced by Makoto Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Nishikawa. The network helps show where Makoto Nishikawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makoto Nishikawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2023 | 0 | |
| 3 | 2021 | 0 | |
| 4 | 2020 | 2 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 1 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 13 | |
| 9 | 2018 | 32 | |
| 10 | 2017 | 6 | |
| 11 | 2017 | 19 | |
| 12 | 2015 | 1 | |
| 13 | 2015 | 7 | |
| 14 | 2015 | 11 | |
| 15 | 2015 | 0 | |
| 16 | 2015 | 5 | |
| 17 | 2012 | 1 | |
| 18 | 2007 | 16 | |
| 19 | 2003 | 32 | |
| 20 | 2000 | 1 |
About Makoto Nishikawa
Makoto Nishikawa is a scholar working on Hepatology, Oncology and Epidemiology, having authored 57 papers that have together received 738 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Respiratory viral infections research (8 papers), Influenza Virus Research Studies (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Neuroendocrine Tumor Research Advances (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Liver physiology and pathology (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Infectious Diseases (243 citations), Hepatology (101 citations) and Epidemiology (400 citations). Makoto Nishikawa has collaborated with scholars based in Japan, Vietnam and Iran. Frequent co-authors include Hiroshi Suzuki, Reiko Saito, Kanako Watanabe, Masaya Higuchi, Masahiro Fujii, Masayasu Oie, Yugo Shobugawa, Asami Sasaki, Fumitake Gejyo and Mizuho Sato.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.